Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Harvard Business School
Mallinckrodt
Dow
Colorcon

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for scyllo-inositol

See Plans and Pricing

« Back to Dashboard

What is the drug development status for scyllo-inositol?

scyllo-inositol is an investigational drug.

There have been 4 clinical trials for scyllo-inositol. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2009.

The most common disease conditions in clinical trials are Alzheimer Disease, Psychomotor Agitation, and Aggression. The leading clinical trial sponsors are Transition Therapeutics Ireland Limited, Elan Pharmaceuticals, and Transition Therapeutics.

Recent Clinical Trials for scyllo-inositol
TitleSponsorPhase
Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseaseElan PharmaceuticalsPhase 2
Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseaseTransition Therapeutics Ireland LimitedPhase 2
Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I DisorderElan PharmaceuticalsPhase 2

See all scyllo-inositol clinical trials

Clinical Trial Summary for scyllo-inositol

Top disease conditions for scyllo-inositol
Top clinical trial sponsors for scyllo-inositol

See all scyllo-inositol clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Express Scripts
Colorcon
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.